Stocks
Latest stock market news — earnings, indices, equities, and corporate events explained for retail investors.
1612 articles in Stocks — page 10 of 135
StocksTruist Lowers Price Target for National Health Investors Following Asset Sale
Truist Securities has adjusted its price target for National Health Investors after a significant asset sale.
StocksStifel Financial Reports Strong Q1 2026 Earnings Despite Stock Dip
Stifel Financial's Q1 2026 earnings exceeded expectations, yet its stock price fell amid market volatility.
StocksBooz Allen Hamilton Shares Decline Following Treasury Secretary's Remarks
Shares of Booz Allen Hamilton dropped after U.S. Treasury Secretary expressed lack of confidence in the firm.
StocksUBS Maintains Neutral Rating on Boston Beer Ahead of Earnings Report
UBS keeps a Neutral rating on Boston Beer, forecasting earnings below consensus ahead of Q1 report.
StocksBMO Increases Alaska Air Price Target to $55 Amid Strategic Developments
BMO Capital has raised Alaska Air's price target to $55, citing strategic progress and growth potential.
StocksMorgan Stanley Increases Teradyne Price Target Amid Networking Growth
Morgan Stanley raises Teradyne's price target to $376, citing networking growth and strong revenue forecasts.
StocksTruist Maintains Positive Outlook on Manhattan Associates Amid Strong Earnings
Truist Securities reaffirms a Buy rating for Manhattan Associates following strong quarterly results.
StocksUBS Lowers GE Aerospace Price Target Amid Geopolitical Concerns
UBS has reduced its price target for GE Aerospace to $350, citing geopolitical issues and market conditions.
StocksCantor Fitzgerald Boosts MKS Instruments Price Target Amid Positive Growth Outlook
Cantor Fitzgerald raises MKS Instruments' price target to $400, citing strong growth potential in semiconductors.
StocksCantor Fitzgerald Maintains Positive Outlook on JFrog Ahead of Earnings
Cantor Fitzgerald reaffirms an Overweight rating on JFrog, anticipating strong cloud growth and upcoming earnings.
StocksCantor Fitzgerald Maintains Positive Outlook on Docebo After Strong Q1 Results
Cantor Fitzgerald reaffirms its positive rating for Docebo following strong preliminary Q1 results.
StocksCantor Fitzgerald Maintains Positive Outlook on National Health Investors Following Portfolio Sale
Cantor Fitzgerald reaffirms an Overweight rating for National Health Investors after its $560 million portfolio sale.